8ª Edição – Especial Simpósio

Lung tumors identified early, with smaller volume, are more likely to be treated

per: Grupo Oncoclínicas
Lung tumors identified early, with smaller volume, are more likely to be treated

Scientific commission

Bruno Ferrari
Bruno Ferrari
Carlos Gil
Carlos Gil
Paula Ugalde
Paula Ugalde
Sérgio Azevedo
Sérgio Azevedo

Contributors

Clarissa Mathias
Clarissa Mathias
Daniel Bonom
Daniel Bonom
Paula Ugalde
Paula Ugalde

Lung cancer is the most victimized in Brazil, and one of the reasons is the late diagnosis – 90% of cases are detected at an advanced stage. Prevention, early detection and novelties in the treatment of cancer, even when diagnosed at a more advanced stage, were some of the topics addressed in the panels dedicated to cancer at the 8th International Symposium on Oncoclinics, held virtually this year.

Oncologist Clarissa Mathias, from NOB, a clinic of Grupo Oncoclínicas welcomes the advancement of new targeted therapies for more aggressive cancers, which benefit from molecular treatment with the definition of more specific targets, remembering that in Brazil there are already approved drugs for EGFR and ALK targets.

The lung module also featured two live surgeries, such as a video-assisted mediastinoscopy (VAMLA), performed by Paula Ugalde, leader in Surgery at Grupo Oncoclínicas, from Hospital Santa Izabel, in Salvador. The EBUS was performed by thoracic surgeon Ricardo Oliveira, from Oncoclínicas da Bahia, and also transmitted directly from the same location. The robotic lobectomy, coordinated by Daniel Bonomi, thoracic surgeon at Oncoclínicas de Belo Horizonte, was also broadcast.

Access our website and read the full report on the news in lung cancer, in addition to all the coverage of the 8th International Oncoclinical Symposium.

Access the full article of this study
Download
Share
Or share the link
Link copied to your desktop.L